MN/CA9 gene expression as a potential biomarker in renal cell carcinoma

BJU International

Volumn 83, Issue 7, 1999, Pages 743-747

  Murakami, Y ^a   Kanda, K ^a   Tsuji, M ^a   Kanayama, H ^a   Kagawa, S ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

MN CA9; Outcome; Renal cell carcinoma; RT PCR; Tumour type

Indexed keywords

BIOLOGICAL MARKER; CELL SURFACE PROTEIN; TUMOR MARKER;

ADULT; AGED; ANALYTICAL EQUIPMENT; ARTICLE; CANCER GRADING; CANCER STAGING; CELL TYPE; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; KIDNEY; KIDNEY CARCINOMA; MALE; ONCOCYTOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; CARBONIC ANHYDRASES; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 0032956387     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1999.00007.x     Document Type: Article

References (20)

1. Der CJ, Stanbridge EJ. A tumor-specific membrane phosphoprotein marker in human cell hybrids. Cell 1981; 26: 429-38
2. Opavsky R, Pastorekova S, Zelnik V et al. Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics 1996; 33: 480-7
3. Pastorek J, Pastorekova S, Callebaut I et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 1994; 9: 2877-88
4. Zavada J, Zavadova Z, Pastorekova S, Ciampor F, Pastorek J, Zelnick V. Expression of MaTu-MN protein in human tumor cultures and clinical specimens. Int J Cancer 1993; 54; 268-74
5. Liao SY, Brewer C, Zavada J et al. Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am J Pathol 1994; 145: 598-609
6. Liao SY, Aurelio ON, Jan K, Zavada J, Stanbridge EJ. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res 1997; 57: 2827-31
7. Gomella LG, Raj GV, Moreno JG. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer. J Urol 1997; 158: 326-37
8. Soeth E, Vogel I, Roder C et al. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res 1997; 57: 3106-10
9. Klein A, Zemer R, Buchmensky V, Klaper R, Nissenkorn I. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma. Cancer 1998; 82: 349-54
10. The Japanese Urological Association, The Japanese Society of Pathology and Japan Radiological Society. The general rules for clinical pathological studies on renal cell carcinoma. 2nd edn. Tokyo 1992
11. Igarashi T, Murakami S, Isaka S, Okano T, Shimazaki J, Matsuzaki O. Serum immunosuppressive acidic protein as a tumor marker for renal cell carcinoma. Eur Urol 1991; 19: 332-5
12. Partin AW, Criley SR, Steiner MS et al. Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor volume. Urology 1995; 45: 211-7
13. Yu CC, Chen KK, Chen MT et al. Serum iron as a tumor marker in renal cell carcinoma. Eur Urol 1991; 19: 54-8
14. Takashi M, Zhu Y, Hasegawa S, Kato K. Serum creatine kinase B subunit in patients with renal cell carcinoma. Urol Int 1992; 48: 144-8
15. Zhu Y, Takashi M, Miyake K, Kato K. An immunochemical and immunohistochemical study of aldolase isozymes in renal cell carcinoma. J Urol 1991; 146: 469-72
16. Takashi M, Haimoto H, Tanaka J, Murase T, Kato K. Evaluation of gamma-enolase as a tumor marker for renal cell carcinoma. J Urol 1989; 141: 830-4
17. Ljungberg B, Rasmuson T, Grankvist K. Erythropoietin in renal cell carcinoma: evaluation of its usefulness as a tumor marker. Eur Urol 1992; 21: 160-3
18. McKiernan JM, Buttyan R, Bander NH et al. Expression of the tumor-associated gene MN. A potential biomarker for human renal cell carcinoma. Cancer Res 1997; 57: 2362-5
19. Nakagawa Y, Uemura H, Hirao Y et al. MN as a potential target in renal cell carcinoma. J Urol 1998; 159: 187
20. McKiernan JM, Stifelman MD, Emanuel ER et al. The molecular detection of renal cancer cells via peripheral blood assay. J Urol 1998; 159: 170